The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs (1版)

類似書籍推薦給您

【簡介】 重量：1.14kg 　頁數：568 裝訂：平裝 　開數：24.3 x 16.9 cm 印刷：雙色 The Maudsley®Deprescribing Guidelines Comprehensive resource describing guidelines for safely reducing or stopping (deprescribing) antidepressants, benzodiazepines, gabapentinoids and z-drugs for patients, including step-by-step guidance for all commonly used medications, covering common pitfalls, troubleshooting, supportive strategies, and more. Most formal guidance on psychiatric medication relates to starting or switching medications with minimal guidance on deprescribing medication. In 2023, the World Health Organisation and the United Nations called for patients, as a human right, to be informed of their right to discontinue treatment and to receive support to do so. The Maudsley Deprescribing Guidelines fills a significant gap in guidance for clinicians by providing comprehensive and authoritative information on this important aspect of treatment. This evidence-based handbook provides an overview of principles to be used in deprescribing. This is derived from fundamental scientific principles and the latest research on this topic, combined with emerging insights from clinical practice (including from patient experts). Building on the recognised brand of The Maudsley Prescribing Guidelines, and the prominence of the authors’ work, including in The Lancet Psychiatry on tapering antidepressants (the most read article across all Lancet titles when it was released). The Maudsley Deprescribing Guidelines covers topics such as: Why and when to deprescribe antidepressants, benzodiazepines, gabapentinoids and z-drugs Barriers and enablers to deprescribing including physical dependence, social circumstances, and knowledge about the discontinuation process Distinguishing withdrawal symptoms, such as poor mood, anxiety, insomnia, and a variety of physical symptoms from symptoms of the underlying disorder that medication was intended to treat The difference between physical dependence and addiction/substance use disorder Explanation of why and how to implement hyperbolic tapering in clinical practice Specific guidance on formulations of medication and techniques for making gradual reductions, including using liquid forms of medication, and other approaches Step-by-step guidance for safely stopping all commonly used antidepressants, benzodiazepines, gabapentinoids and z-drugs, including fast, moderate and slow tapering regimens or schedules for each drug, and guidance on how to tailor these to an individual Troubleshooting issues which can arise on stopping these medications, including akathisia, withdrawal symptoms, acute or protracted, and relapse. Written for anyone interested in safe deprescribing of psychiatric medications including psychiatrists, GPs, pharmacists, nurses, medical trainees, and interested members of the public. The Maudsley Deprescribing Guidelines is an essential resource on the subject that provides practical guidance on how to improve patient outcomes in this field of medicine.

Drugs for the Heart: Expert Consult - Online and Print (8版)

類似書籍推薦給您

24

Koda-Kimble and Young's Applied Therapeutics: The Clinical Use of Drugs (11版)

類似書籍推薦給您

【少量特別書籍 若無貨可能須等候5-7日 因”客制特別調書不收退貨” 可接受在下單】 書名：Koda-Kimble and Young's Applied Therapeutics: The Clinical Use of Drugs(IE) 作者：Zeind 出版社：合記 出版年份：2018 條碼：9781496353795 Continually revised and updated for over 40 years, Applied Therapeutics: The Clinical Use of Drugs is the gold standard for patient-centered drug therapeutics. With its acclaimed case-based approach, the Eleventh Edition promotes mastery and application of the fundamentals of drug therapeutics. Featuring contributions from more than 200 experienced clinicians, every chapter has been revised and updated to reflect our ever-changing knowledge of drugs and the application of this knowledge to the individualized therapy of patients. As you progress from the General Principles section to chapters on specific diseases, you will benefit from practical problem-solving techniques that help you devise effective evidence-based drug treatment plans. Given the evolving educational needs of students, this edition has been thoughtfully revised to align with the five Institute of Medicine (IOM) core competencies (patient-centered care, interdisciplinary teams, evidence-based practice, quality improvement, and informatics), as well as current pharmacy educational outcomes and the North American Pharmacist Licensure Examination (NAPLEX) competency statements. These strategies ensure relevance to contemporary pharmacy and preparation for pharmacy practice. Features to help design safe, effective drug therapy and prepare students for evidence-based practice: Approximately 900 case studies challenge you to integrate and apply therapeutic principles in the context of specific clinical situations, cultivating the critical-thinking skills needed to optimize patient outcomes. Core Principles listed at the beginning of each chapter keep you focused on key content and direct you to specific case studies that enable you to explore critical concepts and gain further understanding of how they apply to evidence-based decision making. New chapters address important recent topics and developments. Drug interactions, pharmacogenomics and personalized medicine, and interprofessional education and practice are included in General Principles; systemic lupus erythematosus in Immunologic Disorders; developmental disorders in Psychiatric Disorders and Substance Abuse; and prostate cancer in Hematology and Oncology. In addition, a chapter has been redesigned to focus on Care of the Critically Ill Adult, which now complements the chapter on Care of the Critically Ill Child.